Showing results (711-720 of 1,001) with videos related to
Sort By:
Pageof 101
Cancer|March 22, 2012
Adherence to surveillance care guidelines after breast and colorectal cancer treatment with curative intentRamzi G Salloum, Mark C Hornbrook, Paul A Fishman, et al.American Journal of Preventive Medicine|March 20, 2012
Using body mass index data in the electronic health record to calculate cardiovascular riskBeverly B Green, Melissa L Anderson, Andrea J Cook, et al.Journal of Occupational and Environmental Medicine|September 7, 2018
Estimating the Impact of Diabetes Mellitus on Worker Productivity Using Self-Report, Electronic Health Record and Human Resource DataDavid C Tabano, Melissa L Anderson, Debra P Ritzwoller, et al.Human Reproduction (Oxford, England)|August 20, 2010
Breast cancer characteristics are modified by first trimester human placenta: in vitro co-culture studyS Tartakover-Matalon, A Mizrahi, G Epstein, et al.Gynecologic Oncology|November 21, 2008
LPA receptor 2 mediates LPA-induced endometrial cancer invasionJoanie Mayer Hope, Feng-Qiang Wang, Jill S Whyte, et al.The American Journal of Managed Care|January 30, 2002
Issues in pooling administrative data for economic evaluationRichard T Meenan, Michael J Goodman, Paul A Fishman, et al.Gynecologic and Obstetric Investigation|August 14, 1998
Estrogen and progesterone receptors in benign ovarian tumors of menopausal breast cancer patients treated with tamoxifenI Cohen, J Bernheim, A Fishman, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|July 1, 1987
Electroretinographic findings in sickle cell retinopathyN S Peachey, H C Charles, C M Lee, et al.Placenta|July 4, 2012
The involvement of eukaryotic translation initiation factor 4E in extravillous trophoblast cell functionE Kitroser, M Pomeranz, G Epstein Shochet, et al.Gynecologic and Obstetric Investigation|January 1, 1997
High frequency of adenomyosis in postmenopausal breast cancer patients treated with tamoxifenI Cohen, Y Beyth, J Shapira, et al.Pageof 101